Powerback’s Post

Our team is in Orlando this week for American Medical Group Association (AMGA)'s Annual Conference. ☀ Swing by booth #815 to learn how the Linus Health platform — a suite of digital cognitive assessment, clinical decision support, and intervention solutions — can enable your medical group or health system to: 🧠 Meet the rising cognitive care needs of older adults 🧠 Streamline testing for signs of Alzheimer's and other dementias 🧠 Boost the bottom line #AMGA #AlzheimersDisease #Alzheimers

Discover how Dance Movement Therapy can support Alzheimer’s patients by using movement to manage stress and process emotions. Kim Rothwell, MA, NCC, BC-DMT, LCPC, LMHC, CADC, shares her insights on how movement can enhance the well-being of individuals with dementia and their caregivers. Read Rothwell's contribution to NBCC’s Counseling Confab at https://lnkd.in/eWGMqpeC.  

Seeking a medical diagnosis for dementia is crucial for early intervention, personalized care, and effective management strategies. Don't delay – early detection empowers us to navigate the journey with knowledge. Follow to learn more! #warrenapatton #author #booklover #dementiahelpguidevol1 #dementiacare #medicaldiagnosis

Recognizing early signs of Alzheimer's is vital for timely intervention and support. Keep an eye out for subtle memory changes, challenges in familiar tasks, and problem-solving difficulties. Early signs may include memory loss, planning difficulties, and confusion. It's essential to track progression and note any changes, as this will help healthcare professionals provide the best care and support. Remember, seeking professional advice is key for an accurate diagnosis and a tailored care plan. Learn more in this link. https://lnkd.in/ge-jizNE  

#healthcareDid you know that only 11% of dementia patients received a cognitive assessment within the five years preceding their diagnosis? Surprised? So was I. Considering the importance of early detection in managing dementia, what are some effective strategies that healthcare providers can use to increase the rate of cognitive assessments? Simplicity for the patient and provider don’t you think would be a great first step Clinical practices can use The Boston Cognitive Assessment (BoCA) a self-administered computerized test designed for longitudinal cognitive monitoring which will reimburse $150-$190 for CPT 96138, CPT 96132 cognitive assessment administration and interpretation. Would love to know your thoughts on this

Being able to distinguish memory loss from dementia is crucial, and detecting the earliest warning signs can be what motivates medical evaluation. Remembering to evaluate key symptoms such as forgetfulness in routine tasks, judgment issues, and progression of forgetfulness over time can allow for an early diagnosis, effective intervention, and improved quality of life. Learn more in this article from the Fisher Center for Alzheimer’s Research Foundation: https://ow.ly/Q1FK50QOMbJ #LongTermCare #KentmereDifference #SkilledNursing

The progression of dementia can be heartbreaking, especially when loved ones begin to forget familiar faces. Understanding the stages at which memory loss affects the recognition of family members is essential for caregivers and families. This guide explores the emotional impact of this experience and provides strategies for coping and maintaining meaningful connections. Read more here: https://lnkd.in/dvSViV83 #CognitiveHealth #DementiaCare #EVYLIGHT #OptoCeutics #BrainHealth --- Claims regarding the effectiveness of EVY LIGHT® and 40 Hz light are based on ongoing research and have not been conclusively proven. EVY LIGHT® follows the published guidelines by FDA for low risk general wellness products and is not subject to FDA medical device regulations. EVY LIGHT® is not intended to diagnose, treat, cure, or prevent any diseases or medical conditions.

How does breaking down care bottlenecks improve dementia treatment? A recent article suggests that improvements in primary care engagement, training, and support can contribute to more effective and timely management of early-stage Alzheimer’s disease. Read more about early detection, reducing wait times, and other key elements that inform how the industry will tackle this condition in the future: https://lnkd.in/eWNHCQP7

According to a recent PsychU survey, 91% of healthcare professionals see stigma negatively impacting patient care. In this interview, “PsychU Section Advisors Discuss Stigma In Agitation Associated With Alzheimer’s Dementia (AAD)”, Drs. Marc Agronin and Ara Khachaturian discuss the findings of this survey and the need for more education on AAD. Watch now! https://go.psychu.org/L0bu #stigma #AAD #Agitation #PsychU

Less Than a Week Away: Care Connection Webinar Thursday, February 8 1PM - 2PM ET Less than a week away, save your spot today! Frontotemporal Degeneration (FTD) is a younger-onset dementia that is frequently misdiagnosed and commonly misunderstood. The majority of people first develop symptoms between 45-64, although the age of onset ranges from 21-80. The initial symptoms of FTD can bring progressive changes to personality, behavior, communication or movement. Join a presentation by the Association for Frontotemporal Degeneration to learn more about: ◆ How FTD differs from Alzheimer's ◆ Signs and symptoms of FTD ◆ The impact of FTD on the person and their caregivers ◆ Resources that can help families and inform and educate healthcare professionals https://lnkd.in/gCE_FB8w